Potassium tetrachloroplatinate(II)

GTC-546

Platinum Compounds

Potassium tetrachloroplatinate(II)

CAS No.
10025-99-7
Catalogue ID
GTC-546

Potassium tetrachloroplatinate(II), CAS 10025-99-7. Source-derived identification, physical data and applications are provided for catalogue reference; request the current specification, COA and SDS for the required grade.

Catalogue aliases / related identifiers

Potassium chloroplatinite; Dipotassium tetrachloroplatinate; Potassium tetrachloroplatinum(II); Platinum potassium chloride (PtK2Cl4); Potassium platinum(II) tetrachloride; Tetrachloroplatinate(II) de potassium; Potassium platinochloride; Potassium tetrachloroplatinite(2-)

Supplied catalogue source: GTC-546 · Page 77

Reference data — confirm before ordering or use

The information below is a structured migration from the supplied catalogue snapshot. It is not a current product specification, COA or SDS. Confirm the actual supplier, grade, batch documents, classification, packing and destination requirements for your enquiry.


Basic Information of Potassium Tetrachloroplatinate(II)

CAS No.10025-99-7
EC No.233-050-9
Chemical FormulaK2PtCl4
Molecular Weight415.09 g/mol
AppearanceReddish-brown to dark red crystalline powder
OdorOdorless
Melting pointDecomposes before melting (>300 °C)
Boiling pointNot applicable (decomposes)
Densityapprox. 3.50 g/cm³
SolubilitySoluble in water (~50 g/L at 20 °C); slightly soluble in ethanol; insoluble in most organic solvents
Nature (hazards)Causes severe skin burns and eye damage, may cause allergic skin reaction, harmful if swallowed, toxic to aquatic life with long lasting effects
RIDADRUN 3288, Toxic solid, inorganic, n.o.s. (Potassium tetrachloroplatinate(II)), Class 6.1, Packing Group III
Chemical StructureMolecular Structure of Potassium Tetrachloroplatinate(II)

Primary Applications of Potassium Tetrachloroplatinate(II)

Potassium Tetrachloroplatinate(II) serves as a fundamental Pt(II) synthon, enabling precise ligand exchange and complex formation in high-value chemical and pharmaceutical processes.

  1. Cisplatin and Platinum Anticancer Agent Synthesis
    Acts as the primary starting material in the industrial and laboratory preparation of cisplatin (cis-[PtCl₂(NH₃)₂]) and related Pt(II) therapeutics via controlled ammine substitution, ensuring high stereochemical purity.

  2. Organometallic Pt(II) Complex Preparation
    Facilitates synthesis of square-planar Pt(II) complexes with phosphines, amines, olefins, or other ligands for homogeneous catalysis, luminescent materials, and mechanistic studies.

  3. Platinum Catalyst Precursor Development
    Used in the generation of supported Pt catalysts or homogeneous Pt species through reduction or ligand modification for hydrogenation, hydrosilylation, and C-C coupling reactions.

  4. Platinum Nanoparticle and Colloid Synthesis
    Enables controlled reduction to produce Pt nanoparticles, clusters, or sols for electrocatalysis, sensors, and biomedical applications requiring defined particle size and high dispersion.

  5. Coordination Chemistry Research
    Serves as a standard Pt(II) source for exploring ligand substitution kinetics, trans effect, and new platinum-containing coordination compounds in academic and industrial labs.

  6. Advanced Materials & Sensors
    Supports preparation of Pt-modified surfaces, electrodes, or functional materials for gas sensors, biosensors, and electrochemical devices with enhanced performance.


  • Consistent High Platinum Content
    Strict analytical controls ensure accurate Pt assay, minimal impurities, and batch-to-batch reproducibility for dependable synthetic outcomes.

  • Secure Precious Metal Sourcing
    Transparent, responsible platinum procurement with inventory management to provide supply stability and competitive pricing.

  • Technical Synthesis Guidance
    Dedicated specialists offer advice on handling, ligand substitution protocols, reduction methods, and process optimization tailored to your applications.

  • Full Regulatory Compliance
    Comprehensive documentation including COA, REACH, RoHS, and detailed SDS to streamline global operations and pharmaceutical-grade requirements.

  • Sustainability & Recycling Support
    Ethical sourcing practices and platinum recovery/recycling programs aligned with ESG objectives and sustainable chemistry principles.


Hazards Classification

  • GHS Classification: Acute Toxicity, Oral (Category 3); Skin Corrosion (Category 1B); Serious Eye Damage (Category 1); Skin Sensitization (Category 1); Aquatic Chronic (Category 2)

  • Hazard Statements: H301: Toxic if swallowed; H314: Causes severe skin burns and eye damage; H317: May cause an allergic skin reaction; H411: Toxic to aquatic life with long lasting effects

  • UN Number: UN 3288

  • Hazard Class: 6.1 (Toxic substances)

  • Packing Group: III

GHS06
GHS06: Acute toxicity
GHS05
GHS05: Corrosive
GHS07
GHS07: Exclamation mark (sensitizer)
GHS09
GHS09: Environment (aquatic toxicity)
Before you order

Confirm the current commercial product record.

Include the required grade or purity, quantity, preferred packing, destination country/port and required document set.

  • 01Current specification
  • 02Batch or sample COA
  • 03Product- and supplier-specific SDS
  • 04Packing and shipping review
Request product review

INQUIRY

INQUIRY